HepaHope, Inc.

HepaHope, Inc.

  • 152 Technology Dr
  • Irvine, California
  • 92618

Website Links

Description

HepaHope, Inc. (the “company”) is a medical device development company that is focused on the research, design, patenting, manufacture, and marketing of life-saving medical device technologies. The company was founded in February 1999 in Silicon Valley, CA to commercialize Bio-Artificial Liver (BAL) technology developed by Dr. Sung-Soo Park, M.D., Ph.D. to meet the urgent need for therapies to treat liver failure and chronic liver diseases. The company holds exclusive USA and international patent rights for the HepaDialyzer™, an extra-corporeal toxin management system that assists a patient’s liver by selectively removing toxins from the bloodstream through metabolic function of the device resembling the function of a healthy liver. A working prototype has been developed and an IND application has been submitted to the FDA to begin human clinical trial. The company expects to have the FDA’s approval for clinical trials in 2007.

Products & services

Similar companies nearby